Chimeric·humanized antibody

Chimeric·humanized antibodies are the most extensively engineered format, fusing a humanized variable region (murine CDRs on a human framework) to a human constant region, achieving humanization at both variable and constant levels. This minimizes non-human sequence content, giving superior immunogenicity and HAMA-risk profiles over chimerics or humanized antibodies alone. Balancing high affinity with low immunogenicity, the format is a key direction for next-generation therapeutic mAbs and high-specificity diagnostics. Recombinant chimeric·humanized antibodies and related variable/constant/CDR proteins support deep humanization, immunogenicity assessment, and WB/IHC/IF/ELISA/FACS.